Literature DB >> 11212319

Beyond blood pressure: new roles for angiotensin II.

R Lucius1, S Gallinat, S Busche, P Rosenstiel, T Unger.   

Abstract

Since the discovery 100 years ago by Tigerstedt and Bergman of renin, an acid protease generating angiotensin peptide, numerous discoveries have advanced our understanding of the renin-angiotensin system (RAS). The recent cloning of angiotensin receptors and the availability of specific receptor ligands have allowed characterization of angiotensin-receptor-mediated actions, and an increasing number of studies using biochemical, pharmacological and molecular biological methods has focused on the many different physiological actions of the RAS in various tissues. Angiotensin II, the main effector peptide of the RAS, exerts most of its known actions in blood pressure control and body fluid homeostasis via the AT, receptor. AT, receptors not only play a role in growth control and cell differentiation but have been implicated in apoptosis and tissue regeneration. This review focuses on the extrarenal functions of angiotensin, especially in neuronal cells and the nervous system, and on recent advances in angiotensin receptor research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11212319     DOI: 10.1007/s000180050490

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

Review 1.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

3.  Physiological changes in maternal cortisol do not alter expression of growth-related genes in the ovine placenta.

Authors:  E C Jensen; M Rochette; L Bennet; C E Wood; A J Gunn; M Keller-Wood
Journal:  Placenta       Date:  2010-10-15       Impact factor: 3.481

4.  Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration.

Authors:  Mathieu Cotton; Pierre-Luc Boulay; Tanguy Houndolo; Nicolas Vitale; Julie A Pitcher; Audrey Claing
Journal:  Mol Biol Cell       Date:  2006-11-22       Impact factor: 4.138

Review 5.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 6.  Cardiovascular risk and management in chronic kidney disease.

Authors:  Diana Rucker; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

7.  Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.

Authors:  Yan Huang; Annarita Di Lorenzo; Weidong Jiang; Anna Cantalupo; William C Sessa; Frank J Giordano
Journal:  Hypertension       Date:  2013-08-05       Impact factor: 10.190

Review 8.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

9.  Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system.

Authors:  Anuradha Chakrabarty; Audrey Blacklock; Stanislav Svojanovsky; Peter G Smith
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

Review 10.  The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers.

Authors:  J Culman; A Blume; P Gohlke; T Unger
Journal:  J Hum Hypertens       Date:  2002-08       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.